Craft
Cambrex

Cambrex

Revenue

$532.1 M

FY, 2018

Market Capitalization

$2 B

2019-12-05

Cambrex Summary

Company summary

Overview
Cambrex is a global market leader in branded and generic small molecule active pharmaceutical ingredients (APIs), advanced intermediates, custom development and manufacturing and controlled substances. Our pharmaceutical products, technologies and expertise accelerate your small molecule therapeutics into the market.
Type
Public
Founded
1981
HQ
East Rutherford, NJ, US | view all locations
Website
https://www.cambrex.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Thomas Loewald

    Thomas Loewald, Chief Executive Officer

    • Tom Vadaketh

      Tom Vadaketh, Executive Vice President and Chief Financial Officer

      • Samantha M. Hanley

        Samantha M. Hanley, Senior Vice President and General Counsel

        • Robert Green

          Robert Green, Executive Vice President and Chief Financial Officer

          LocationsView all

          3 locations detected

          • East Rutherford, NJ HQ

            United States

            1 Meadowlands Plaza

          • Charles City, IA

            United States

            1205 11th St

          • Björkborn, Örebro County

            Sweden

          Cambrex Financials

          Summary financials

          Revenue (Q3, 2019)
          $148.6M
          Gross profit (Q3, 2019)
          $50.9M
          Net income (Q3, 2019)
          $9.5M
          Cash (Q3, 2019)
          $80.8M
          EBIT (Q3, 2019)
          $17.5M
          Enterprise value
          $2.4B

          Footer menu